Le Lézard
Classified in: Ebola virus, Health
Subject: ACC

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2022


GOTHENBURG, Sweden, Nov. 3, 2022 /PRNewswire/ -- Zinzino group revenue increased with a total of 22%, compared with the previous year.

The revenue in October for Zinzino's sales markets increased by 22% and amounted to SEK 125.4 (102.4) million. Faun Pharma's external sales increased by 12% and amounted to SEK 4.8 (4.3) million. Overall, the Group increased revenues by 22% to SEK 130.2 (106.7) million compared with the previous year.

Accumulated revenue for January ? October 2022 increased by 6% to SEK 1144.0 (1076.1) million.

Revenues were distributed as follows:

                                   

                                   

Regions, mSEK

                                   

22-Oct

                                   

21-Oct

                                   

Change

                                   

YTD 2022

                                   

YTD 2021

                                   

Change

                                               

                                   

The Nordics

 

27.8

 

29.2

 

-5 %

 

263.5

 

300.4

 

-12 %

 

                                   

Central Europe

 

27.3

 

18.1

 

51 %

 

223.7

 

180.6

 

24 %

 

                                   

East Europe

 

29.8

 

24.3

 

23 %

 

267.6

 

262.3

 

2 %

 

                                   

South & West Europe

 

15.8

 

11.5

 

37 %

 

129.9

 

114.4

 

14 %

 

                                   

The Baltics

 

6.7

 

6.1

 

10 %

 

59.3

 

58.3

 

2 %

 

                                   

North America

 

11.0

 

4.4

 

150 %

 

63.1

 

40.5

 

56 %

 

                                   

Asia-Pacific

 

5.9

 

8.8

 

-33 %

 

63.5

 

68.1

 

-7 %

 

                                   

Africa

 

1.1

 

0.0


 

7.3

 

0.0


                                   

Zinzino

 

125.4

 

102.4

 

22 %

 

1077.9

 

1024.6

 

5 %

 

                                   

Faun Pharma

 

4.8

 

4.3

 

12 %

 

66.1

 

51.5

 

28 %

 

                                   

Zinzino Group

 

130.2

 

106.7

 

22 %

 

1144.0

 

1076.1

 

6 %

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlansds, Slovenia, Spain, United Kingdom, Belgium, Ireland
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen
CEO Zinzino
+47 (0) 932 25 700,
zinzino.com

Pictures for publication free of charge:
[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 09:00 the 3rd of November 2022.

The following files are available for download:

https://mb.cision.com/Main/10976/3660370/1647946.pdf

2210 Pressrelease Salesreport EN

 


These press releases may also interest you

at 23:17
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

at 20:07
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:00
Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 19:54
British Columbia designates Psychotherapy under the Health Professions Act
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

at 19:52
Whitman-Walker Institute Condemns Nationwide Injunction Blocking Federal Nondiscrimination Protections for Transgender People Following a 'Shameful' Decision in Tennessee Case
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...

at 19:22
Baixiang brand Instant Noodles recalled due to undeclared peanut
Product: Instant Noodle Issue: Food - Allergen - Peanut Distribution: AlbertaBritish ColumbiaOntario See the affected products and product photos for this recall Company information Five Continents International Ltd. Telephone: 416-292-6766| Fax:...

More news about Health...


News published on and distributed by: